Acurx Pharmaceuticals Inc...
(ACXP)
undefined
undefined%
At close: undefined
0.86
1.08%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Operating Income | -14.58M | -12.09M | -12.88M | -4.60M | -5.93M |
Interest Income | - | - | - | - | - |
Pretax Income | -14.58M | -12.09M | -12.75M | -4.60M | -5.93M |
Net Income | -14.58M | -12.09M | -12.68M | -4.60M | -5.93M |
Selling & General & Admin | 8.53M | 7.34M | 10.78M | 2.40M | 2.42M |
Research & Development | 6.04M | 4.75M | 2.03M | 2.20M | 3.51M |
Other Expenses | - | - | - | - | - |
Operating Expenses | 14.58M | 12.09M | 12.81M | 4.60M | 5.93M |
Interest Expense | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 14.58M | 12.09M | 12.81M | 4.60M | 5.93M |
Income Tax | - | -1.22K | -66.50K | -4.60K | -5.93K |
Shares Outstanding (Basic) | 12.67M | 10.82M | 10.22M | 9.92M | 9.92M |
Shares Outstanding (Diluted) | 12.67M | 10.82M | 10.22M | 9.92M | 9.92M |
EPS (Basic) | -1.15 | -1.12 | -1.24 | -0.46 | -0.6 |
EPS (Diluted) | -1.15 | -1.12 | -1.24 | -0.46 | -0.6 |
EBITDA | - | -12.09M | - | -4.60M | -5.93M |
Depreciation & Amortization | 14.58M | 12.09M | 12.81M | 4.60M | 5.93M |